INmune Bio
INMB
#10573
Rank
S$41.88 M
Marketcap
S$1.35
Share price
0.00%
Change (1 day)
-28.63%
Change (1 year)

Earnings for INmune Bio (INMB)

Earnings in 2026 (TTM): -S$23.71 Million

According to INmune Bio's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$59.19 Million a decrease over its 2024 earnings that were of -S$54.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for INmune Bio from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$23.71 Million-59.96%
2025 -S$59.19 Million9.15%
2024 -S$54.23 Million40.24%
2023 -S$38.67 Million9.92%
2022 -S$35.18 Million-10.02%
2021 -S$39.1 Million150.76%
2020 -S$15.6 Million57.58%
2019 -S$9.9 Million-38.28%
2018 -S$16.03 Million